Collagen’s unique hierarchical assembly, from molecules to fibrils to fibers, imparts anisotropic mechanical properties that are vital for tissue-specific function. Traditional methods of collagen orientation, including magnetic alignment and electrospinning, encounter significant limitations. Magnetic techniques risk embedding residual magnetic beads that compromise biocompatibility, while electrospinning requires volatile organic solvents that raise safety concerns and complicate clinical translation. The innovative method designed by the YOKOHAMA team circumvents these pitfalls by using pure type I collagen solutions combined with cells, shaped in microfluidic channels fabricated by 3D printing, thereby eliminating the need for extraneous chemicals or particles.

This technique fundamentally hinges on harnessing controlled fluid flow within the microchannels to direct fiber orientation. By carefully designing flow patterns through the fluidic device, the researchers induced collagen molecules and fibroblast cells to align along predetermined directions. Unlike previous orientation methods that typically produce unidirectional alignment, this system achieved precise multidirectional arrangement at a microscale level. The fluidic channels themselves act as versatile scaffolds, enabling the fabrication of tissue constructs with complex, biomimetic architectures closely resembling the interfibrillar arrangements in native tissues such as the dermal layer of skin or the compact bone’s lamellae.

The research explored the interplay between flow velocity, channel geometry, and cellular behavior to optimize collagen fiber alignment while maintaining cell viability and function. By mixing the type I collagen precursor with living cells before being injected into the flow channels, the process allowed for simultaneous fiber orientation and cell alignment—a crucial factor that influences cell morphology, migration, and differentiation. The resultant hydrogels exhibited remarkably fine control over fiber diameter, bundle size, and directionality, attributes that traditional fabrication platforms seldom achieve with such scalability and reproducibility.

From a materials science perspective, this advancement is significant because it offers a tunable, solvent-free method to manufacture hydrogels with hierarchical structural fidelity. The precise micro-orientation of collagen fibers is crucial, as it dictates the mechanical anisotropy that supports physiological functions such as load bearing, tensile strength, and cellular signaling. By guiding the fluid flow in multiple directions within a single construct, the researchers successfully engineered tissues with spatially varying fiber orientations—a biomimetic trait previously limited to natural tissues and challenging to replicate artificially.

Moreover, the use of 3D-printing technology to fabricate the master molds enables rapid prototyping and customization of channel geometries, paving the way for personalized tissue models. This feature is particularly promising for developing in vitro platforms that replicate patient-specific tissue microenvironments. Such platforms could revolutionize drug testing, disease modeling, and regenerative therapies by providing physiologically relevant scaffolds that closely emulate the anisotropic nature of human tissues.

The implications for translational medicine are substantial. As the orientation of collagen fibers profoundly impacts cell function—regulating behavior, differentiation, and extracellular matrix remodeling—engineered tissues that accurately reproduce these orientations have the potential to improve graft integration and functionality in vivo. For example, in skin grafts intended for burn victims or reconstructive surgeries, replicating the dermis’s multidirectional collagen fiber orientations could enhance mechanical durability and accelerate healing.

Kazutoshi Iijima, associate professor and one of the principal investigators of the study, explains that their fluidic alignment system offers a scalable and cost-effective alternative to existing fabrication methods. Without relying on volatile solvents or magnetic particles, the approach supports safer production standards suitable for clinical applications. "By manipulating flow channels constructed through 3D printing, we have demonstrated that simultaneously orienting collagen fibers and living cells in multiple directions is feasible—a breakthrough that closely mimics native tissue architectures," he remarks.

This strategy’s ability to fine-tune fiber orientation extends beyond skin and bone tissue models. In principle, it can be adapted to a variety of biological tissues where anisotropic properties are crucial, such as cardiac muscle, tendons, and neural tissues. The researchers envision a future where customizable hydrogels serve as scaffolds for organoids or implantable constructs that can guide tissue regeneration with unprecedented precision.

Importantly, the study contributes to a deeper understanding of how biophysical cues generated by fluid flow influence cell alignment and extracellular matrix assembly. The dual role of the fluidic environment in simultaneously shaping collagen fibrils and orienting fibroblast cells hints at fundamental mechanobiological principles that govern tissue morphogenesis. This knowledge can inform the design of next-generation biomaterials capable of directing cell fate and improving therapeutic outcomes.

Further development of this platform includes exploring co-culture systems where multiple cell types interact within oriented hydrogels, thereby mimicking the cellular heterogeneity of native tissues. Additionally, integrating sensor technologies within the flow system could enable real-time monitoring of fiber alignment and cell behavior, facilitating adaptive fabrication processes.

As this technology matures, it promises to fortify the bridge between biomimetic tissue engineering and practical clinical applications. The use of fluidics and 3D printing to sculpt collagen hydrogels with multiscale, multidirectional orientation heralds a new era in fabricating tissue models that not only replicate biological form but also recapitulate function. This advancement aligns with the overarching goal of regenerative medicine: to restore damaged tissues with constructs indistinguishable from their natural counterparts, thereby enhancing patient outcomes and quality of life.

This groundbreaking research was published in the journal ACS Biomaterials Science and Engineering on May 12, 2025, and funded by the Japan Science and Technology Agency. The multidisciplinary team at YOKOHAMA National University, encompassing engineering science and biomedical faculties, spearheaded this innovative work that integrates principles from polymer chemistry, bioengineering, and cell biology. Their contributions underscore the growing convergence of applied sciences and life sciences in solving critical biotechnological challenges.

As the global scientific community continues to unravel collagen’s multifaceted roles and develop tools to manipulate its structure, this fluidic-oriented fabrication method stands out as a transformative platform. By combining the precision of microfluidics with the versatility of 3D printing, this approach marks a significant milestone in tissue engineering, setting the stage for futuristic therapies that harness the power of anisotropic biomaterials.

Subject of Research: Collagen fiber orientation, tissue engineering, fluidic alignment, 3D printed microfluidic devices, biomaterial scaffolds

Article Title: Fabrication of Multiscale, Multidirectional Orientated Collagen Hydrogels with Guided Cell Alignment Using Fluidics and a Three-Dimensional Printing

News Publication Date: 12-May-2025

Web References: https://pubs.acs.org/doi/10.1021/acsbiomaterials.4c02156

References: DOI: 10.1021/acsbiomaterials.4c02156

Image Credits: YOKOHAMA National University

Keywords

Collagen, Hydrogels, Tissue engineering, Tissue, Fibroblasts, Mesenchymal stem cells

The innovative approach involves the manipulation of light to interact with hydrogels, a versatile material often used in 3D bioprinting. By refining the properties of light, the researchers succeeded in altering the internal structure of these hydrogels to guide the behavior and growth patterns of cells embedded within. This cutting-edge method addresses long-standing challenges in recapitulating the complex environments of human tissues, paving the way for more effective therapies aimed at repairing damaged organs and tissues.

Dr. Johnson V. John, the lead investigator of the study, expressed the potential of their technique in revolutionizing how microtissues are created. “Our method allows for the fabrication of microtissue with highly precise structural qualities,” Dr. John stated, emphasizing the technique’s importance in shaping engineered tissues such as muscle and retinal structures. By introducing this novel class of biomaterials, the research team is setting the stage for a new wave of tissue engineering that can actively facilitate the formation of viable tissues through a bottom-up approach.

The applications of these microgels are manifold, as shown in experiments where muscle cells were integrated into rod-shaped gels. This configuration not only aided the alignment of muscle cells but also encouraged the formation of muscle fibers. Such progress is particularly encouraging for developing injectable treatments aimed at repairing muscle injuries, which could potentially transform rehabilitation processes for patients with muscle damage.

Furthermore, the research team demonstrated the versatility of their microgels by utilizing them to hold photoreceptor cells, which autonomously organized into structures resembling the outer layers of the retina. This discovery has sweeping implications for future therapies targeting retinal diseases that impact vision, showcasing how the aligning of cells can lead to functionalities traditionally found in biological tissues. The integration of angiogenic peptides within these microgels further promotes the development of new blood vessels, thereby enhancing both in vitro and in vivo tissue engineering outcomes.

Key to the success of this research is the ability of the microgels to retain their form during the injection process. This stability ensures that the materials can effectively support not only cell growth but also facilitate new blood vessel formation, which is critical for tissue development and repair. The flexible design framework of these microgels allows for customization across various clinical applications, making them a promising tool in the realms of wound healing, organ repair, and disease study.

Dr. Ali Khademhosseini, the CEO of TIBI, praised the research, noting its potential to bridge significant gaps in conventional medical practices. “This research marks a monumental advancement in our quest to create structures that can develop into functional tissues,” Dr. Khademhosseini reflected. By fusing light-based fabrication techniques with sophisticated biomaterials, TIBI is edging closer to realizing minimally invasive, personalized therapeutic options that could revolutionize patient care.

The impact of this study is underscored by the support it received from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and TIBI itself. The collaboration reflects a concerted effort to push boundaries in biomedical innovation and establish effective treatments grounded in cutting-edge scientific research. With potential applications extending far beyond traditional uses, the implications of this work are profound.

The use of light-based technologies in bioprinting ensures that finer control can be maintained over cellular environments, a crucial factor in replicating the natural structural complexities experienced within biological tissues. The study paves the way for future exploration into more adaptive materials for tissue engineering, where dynamic properties can enhance recovery processes post-treatment.

As the medical field advocates for advancements in personalized medicine, the findings presented in this research represent a compelling leap towards integrating sophisticated materials with patient-specific solutions. By continuously refining and innovating these strategies, the Terasaki Institute is positioning itself at the forefront of a transformative era in tissue engineering and biomedical research.

As researchers continue to explore the macro- and micro-level intricacies of tissue formation and functionality, the potential of intelligently designed biomaterials to revolutionize medical treatments remains a primary focus. This study not only enriches the scientific landscape with new methodologies but also lays the groundwork for future innovations in organ regeneration and tissue repair strategies, potentially offering solutions to pressing health challenges faced by millions worldwide.

In conclusion, this research embodies the interplay between engineering, biology, and medicine, a synergy that is essential as we strive toward innovative solutions in healthcare. The Terasaki Institute’s dedication to advancing biomedical innovations through rigorous research is set to shape the future of therapeutic interventions, providing a beacon of hope for many in need of advanced regenerative treatments.

—

Subject of Research: Not applicable
Article Title: Filamented Light (FLight) Biofabrication of Aligned Fibrillar Structures to Direct 3D Cell Organization Within Microgels
News Publication Date: 10-May-2025
Web References: http://dx.doi.org/10.1002/smll.202500261
References: Not applicable
Image Credits: Terasaki Institute

Keywords

Tissue engineering, 3D bioprinting, microgels, cell organization, biomedical innovation, regenerative medicine, personalized therapy, light-based fabrication.

Alexandra Rutz, an assistant professor of biomedical engineering at the McKelvey School of Engineering, along with Somtochukwu Okafor, a doctoral student under her guidance, has successfully 3D printed bioelectronic scaffolds designed to aid in new tissue formation. This endeavor aligns with advancements in health care where 3D printing is already making strides by producing prosthetics and dental implants. The dimensions of these advanced scaffolds are quite small, measuring roughly 6 millimeters in diameter, comparable to a pencil eraser, and they are suspended in a water-based medium that supports their functionality.

The key innovation in Rutz and Okafor’s research lies in their choice of materials. Traditionally, scaffold materials have been synthetic or derived from natural substances, but this team has opted for what they describe as "functional materials." These materials possess specific properties purposely engineered to perform designated functions, such as electronic conductivity. By utilizing the conducting polymer PEDOT:PSS, they have developed hydrophilic scaffolds that maintain their conductive properties even in aqueous environments, thus offering a unique solution for interfacing with living organisms.

The exploration of bioelectronics is not entirely new, with devices like cochlear implants and pacemakers serving as common examples. However, the Washington University team is attempting to forge new pathways by integrating traditional approaches from tissue engineering with contemporary bioelectronic materials. The goal is to create a seamless interface where living systems and electronic systems can work in tandem, analogous to natural biological processes. This multidisciplinary approach amalgamates distinct advantages of 3D printing, tissue engineering, and bioelectronics into a cohesive framework with expansive potential.

Scaffold functionality is critical in dictating cell behavior, including adhesion, migration, and proliferation. The unique characteristics of the hydrogels utilized in Rutz’s lab prove beneficial in this regard. The porous structures within these bioelectronic scaffolds are specifically designed to be 150-300 microns wide, thereby influencing cellular interactions and supporting growth patterns. The lattice configuration not only accommodates the movement of cells but also provides a stable structure to prevent them from detaching and collapsing.

Rutz emphasizes that the incorporation of soft, conductive materials heralds a significant advancement in scaffold technology. Unlike traditional stiff materials, their scaffolds offer a more native-like environment for cells, thus fostering improved tissue development. This is crucial, particularly in applications aimed at regenerating soft tissues that are inherently more pliable compared to their rigid counterparts.

The versatility of the bioelectronic scaffolds opens doors to diverse applications. One of the primary visions for this research is the implementation of "tissues-on-chips" technology. This innovative concept could play a vital role in drug development, toxicology studies, and environmental impact assessments, all while facilitating valuable insights into human physiology in controlled laboratory conditions.

The research team has not just focused on the fabrication of these novel scaffolds; they are also proactively seeking to secure intellectual property rights. In collaboration with the institution’s Office of Technology Management, Rutz and Okafor have submitted a patent application for their 3D printing methods, underscoring their commitment to protecting and promoting their cutting-edge work.

Funding for this ambitious research project has been bolstered by Washington University in St. Louis as well as grants from the National Science Foundation, emphasizing the significance of financial support in advancing scientific discovery. The collaborative nature of this research exemplifies the potential of interdisciplinary work, as engineers and biologists converge to explore the intricate relationship between technology and living systems.

As research continues, the implications of bioelectronic scaffolds that possess similar properties to soft tissues are profound. They represent a transformative step toward the development of advanced medical devices and treatments, potentially enabling breakthroughs in regenerative medicine that were previously confined to theoretical discussions. The outcomes of this research may pave the way for the next generation of medical technologies, thereby impacting countless lives.

Among the many challenges that lie ahead, one remains paramount: ensuring that these bioelectronic scaffolds can be effectively integrated into the complex dynamics of biological systems. The ongoing investigations aim to refine the scaffolds further, enhancing their performance while ensuring compliance with biological requirements. Future phases of research will delve deeper into how these advanced materials interact with various types of cells and the long-term implications of their use in regenerative therapies.

In summary, the pioneering work being undertaken at Washington University in St. Louis signifies a crucial advancement in the fields of bioengineering and healthcare technology. By blending 3D printing with bioelectronics, Rutz and Okafor are setting the stage for innovations that could redefine the landscape of tissue engineering and regenerative medicine. The excitement surrounding this research points towards a future where electronics and biology coalesce seamlessly, leading to remarkable enhancements in medical innovation and patient care.

Subject of Research: Development of Bioelectronic Scaffolds for Tissue Engineering
Article Title: Washington University’s Groundbreaking Bioelectronic Scaffolds Pave the Way for Revolutionary Tissue Engineering Applications
News Publication Date: October 2023
Web References:
References: Okafor SS., Park J, Liu T, Goestenkors AP, Alvarez RM, Semar BA, Yu JS, O’Hare CP, Montgomery SK, Friedman LC, Rutz AL. 3D printed bioelectronic scaffolds with soft tissue-like stiffness. Advanced Materials Technologies, published online Feb. 4, 2025. DOI:
Image Credits: Washington University in St. Louis

Keywords

Bioelectronics, biomedical engineering, 3D printing, tissue engineering, regenerative medicine, bioelectronic scaffolds, PEDOT:PSS, tissues-on-chips.